RE: You might like to read this.19 Feb 2021 19:02
The lateral flow test developed by Yorkshire biotech firm Avacta boasts a higher accuracy than American devices currently imported in huge numbers by the government, but is also much faster.
As I understand it these lateral flow tests often give a positive result on fragments of the virus.
Someone has had Covid and recovered, is no longer capable of passing it on, but there are
fragments of virus still present.
Our test will only give a positive result in the presence of a complete virus and is
extremely sensative.
So a person tested may have only just been infected, has a low viral load, increasing
rapidly and is infectious.
A vastly better test - if it works of course and that is the risk.